Evaxion - PE Ratio 2020-2024 | EVAX

Current and historical p/e ratio for Evaxion - (EVAX) from 2020 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Evaxion - PE ratio as of May 27, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Evaxion - PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-05-28 2.63 0.00
2024-09-30 15.55 $-21.30 0.00
2024-06-30 14.50 $-33.60 0.00
2023-06-30 65.50 $-52.50 0.00
2022-06-30 96.00 $-55.50 0.00
2022-03-31 151.50 $-63.50 0.00
2021-12-31 221.00 $-62.50 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.003B $0.003B
Evaxion A/S is a clinical-stage TechBio company specializing in developing AI-Immunology(TM) powered vaccines. Evaxion A/S, formerly known as Evaxion Biotech A/S, is based in COPENHAGEN, Denmark.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.731B 53.50
Hims & Hers Health (HIMS) United States $11.944B 124.09
Tempus AI (TEM) United States $11.403B 0.00
IRhythm Technologies (IRTC) United States $4.673B 0.00
Inspire Medical Systems (INSP) United States $4.222B 65.97
Privia Health (PRVA) United States $2.843B 194.33
Enovis (ENOV) United States $1.910B 10.65
Clover Health Investments (CLOV) United States $1.634B 0.00
Schrodinger (SDGR) United States $1.578B 0.00
Phreesia (PHR) United States $1.484B 0.00
Omnicell (OMCL) United States $1.387B 24.47
Azenta (AZTA) United States $1.269B 58.98
10x Genomics (TXG) United States $1.058B 0.00
Butterfly Network (BFLY) United States $0.626B 0.00
Fulgent Genetics (FLGT) United States $0.615B 0.00
Talkspace (TALK) United States $0.494B 147.50
Veradigm (MDRX) United States $0.460B 0.00
Claritev (CTEV) United States $0.450B 0.00
Standard BioTools (LAB) United States $0.391B 0.00
TruBridge (TBRG) United States $0.361B 801.00
Outset Medical (OM) United States $0.333B 0.00
Nyxoah SA (NYXH) Belgium $0.264B 0.00
Health Catalyst (HCAT) United States $0.263B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.193B 0.00
KORU Medical Systems (KRMD) United States $0.134B 0.00
EUDA Health Holdings (EUDA) Singapore $0.134B 0.00
Pulmonx (LUNG) United States $0.124B 0.00
American Well (AMWL) United States $0.109B 0.00
MDxHealth SA (MDXH) Belgium $0.100B 0.00
CareCloud (CCLD) United States $0.087B 3.32
111 (YI) China $0.069B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
P3 Health Partners (PIII) United States $0.052B 0.00
Zepp Health (ZEPP) Netherlands $0.037B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.024B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
Precipio (PRPO) United States $0.015B 0.00
Strata Skin Sciences (SSKN) United States $0.012B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Streamline Health Solutions (STRM) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
HeartSciences (HSCS) United States $0.005B 0.00
Movano (MOVE) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00